Get started
Valneva SEValneva SEValneva SE

Valneva SE

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

INRLF chart


Full chart

INRLF upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪323.35 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.05 USD
Net income (FY)
‪−111.95 M‬ USD
Revenue (FY)
‪169.66 M‬ USD
Shares float
‪135.91 M‬
Beta (1Y)
0.77

Employees


Employees (FY)
676
Revenue / Employee (1Y)
‪250.98 K‬ USD
Net income / Employee (1Y)
‪−165.61 K‬ USD

About VALNEVA SE


Sector
Health Technology
Industry
Biotechnology
CEO
Thomas Lingelbach
Website
valneva.com
Headquarters
Saint-Herblain
Founded
1999
ISIN
FR0004056851
FIGI
BBG004SNW0T3
Valneva SE is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases addressing unmet medical needs. It currently provides three proprietary travel vaccines: IXIARO, DUKORAL, and IXCHIQ. The IXIARO is an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis in adults, adolescents, children, and infants aged two months and older. The DUKORAL is a drinkable vaccine that helps prevent diarrhea caused by heat-labile toxin-producing ETEC, as well as cholera. The IXCHIQ is a single-dose, live-attenuated vaccine for the prevention of disease caused by chikungunya virus. The company also offers additional vaccines, including VLA1553, VLA15, VLA160, VLA200, VLA1601 and others. Valneva was founded on May 28, 2013 and is headquartered in Saint-Herblain, France.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

INRLF news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of INRLF is 2.10 USD — it has increased by 11.70% in the past 24 hours. Watch Valneva SE stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Valneva SE stocks are traded under the ticker INRLF.
INRLF stock has risen by 6.06% compared to the previous week, the month change is a −4.55% fall, over the last year Valneva SE has showed a −60.00% decrease.
We've gathered analysts' opinions on Valneva SE future price: according to them, INRLF price has a max estimate of 11.62 USD and a min estimate of 3.01 USD. Watch INRLF chart and read a more detailed Valneva SE stock forecast: see what analysts think of Valneva SE and suggest that you do with its stocks.
INRLF reached its all-time high on Nov 29, 2021 with the price of 33.35 USD, and its all-time low was 1.97 USD and was reached on Dec 19, 2024. View more price dynamics on INRLF chart.
See other stocks reaching their highest and lowest prices.
INRLF stock is 10.48% volatile and has beta coefficient of 0.77. Track Valneva SE stock price on the chart and check out the list of the most volatile stocks — is Valneva SE there?
Today Valneva SE has the market capitalization of ‪335.46 M‬, it has increased by 6.81% over the last week.
Yes, you can track Valneva SE financials in yearly and quarterly reports right on TradingView.
Valneva SE is going to release the next earnings report on Mar 20, 2025. Keep track of upcoming events with our Earnings Calendar.
INRLF earnings for the last quarter are −0.06 USD per share, whereas the estimation was −0.14 USD resulting in a 58.33% surprise. The estimated earnings for the next quarter are −0.10 USD per share. See more details about Valneva SE earnings.
Valneva SE revenue for the last quarter amounts to ‪50.99 M‬ USD, despite the estimated figure of ‪50.05 M‬ USD. In the next quarter, revenue is expected to reach ‪58.10 M‬ USD.
INRLF net income for the last quarter is ‪−10.28 M‬ USD, while the quarter before that showed ‪−26.71 M‬ USD of net income which accounts for 61.49% change. Track more Valneva SE financial stats to get the full picture.
No, INRLF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 25, 2024, the company has 676.00 employees. See our rating of the largest employees — is Valneva SE on this list?
Like other stocks, INRLF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Valneva SE stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Valneva SE technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Valneva SE stock shows the sell signal. See more of Valneva SE technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.